Common Contracts
3 similar Master Clinical Study Agreement contracts by Juno Therapeutics, Inc.
EX-10.9 8 d772541dex109.htm MASTER CLINICAL STUDY AGREEMENT, MEMORIAL SLOAN- KETTERING CANCER CENTER [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment...Master Clinical Study Agreement • May 5th, 2020 • New York
This Master Clinical Study Agreement is entered into as of November 21, 2013 (the “Effective Date”), by and between Memorial Sloan-Kettering Cancer Center (“MSKCC”), a New York nonprofit corporation, and Juno Therapeutics, Inc. (“Sponsor”), a Delaware corporation.
MASTER CLINICAL STUDY AGREEMENTMaster Clinical Study Agreement • December 16th, 2014 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Master Clinical Study Agreement is entered into as of November 21, 2013 (the “Effective Date”), by and between Memorial Sloan-Kettering Cancer Center (“MSKCC”), a New York nonprofit corporation, and Juno Therapeutics, Inc. (“Sponsor”), a Delaware corporation.
MASTER CLINICAL STUDY AGREEMENTMaster Clinical Study Agreement • November 17th, 2014 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Master Clinical Study Agreement is entered into as of November 21, 2013 (the “Effective Date”), by and between Memorial Sloan-Kettering Cancer Center (“MSKCC”), a New York nonprofit corporation, and Juno Therapeutics, Inc. (“Sponsor”), a Delaware corporation.
